Clinical Trial Update: The Effect of Rituximab on the Development of Anti-Donor Antibodies [NA]

View source ↗

Summary

A completed clinical trial evaluated whether rituximab affects the development of anti-donor antibodies in renal transplant rejection. Results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejection

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Renal Transplant Rejection | NA | Status: COMPLETED | Results posted: 2014-03-26